 |
Corporate News
22-Apr-21
|
|
|
|
|
|
|
|
|
|
|
|
Caplin receives USFDA approval for Neostigmine Methylsulfate Injection
|
|
|
|
|
|
|
|
Caplin Steriles (Caplin), a Subsidiary Company of Caplin Point
Laboratories, has been granted final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Neostigmine Methylsulfate Injection USP, 5 mg/10 mL (0.5 mg/mL) and 10 mg/10 mL (1 mg/mL), Multiple-Dose vial presentations, a generic therapeutic equivalent version of (RLD), BLOXIVERZ Injection, of Exela Pharma Sciences, LLC, USA.
Neostigmine Methylsulfate Injection is a cholinesterase inhibitor and is indicated for the reversal of the effects of non-depolarizing neuromuscular blocking agents (NMBAs) after surgery. According to IQVIATM (IMS Health), Neostigmine Methylsulfate Injection had US sales data of approximately $20 million for the 12-month period ending Dec 2020.
|
|
|
|
Previous News |
Caplin Point Laboratories standalone net profit rises 20.60% in the June 2023 quarter
(
Results
-
Announcements
07-Aug-23
18:19
)
|
|
|
Caplin Point Laboratories fixes record date for final dividend
(
Market Beat
-
Reports
07-Aug-23
19:06
)
|
|
|
Caplin Point Laboratories allots 1,400 equity shares under ESOP
(
Corporate News
-
16-Jul-24
19:21
)
|
|
|
Caplin Point Laboratories consolidated net profit rises 29.16% in the March 2023 quarter
(
Results
-
Announcements
27-May-23
13:27
)
|
|
|
Caplin Point Laboratories to table results
(
Corporate News
-
29-Jul-22
15:40
)
|
|
|
Caplin Point Laboratories to hold board meeting
(
Corporate News
-
01-Aug-23
12:57
)
|
|
|
Caplin Point Laboratories fixes record date for interim dividend
(
Market Beat
-
Reports
04-Mar-20
12:51
)
|
|
|
Caplin Point Laboratories consolidated net profit rises 21.70% in the June 2023 quarter
(
Results
-
Announcements
08-Aug-23
07:33
)
|
|
|
Caplin Point Laboratories undertakes restructuring of subsidiary
(
Corporate News
-
30-Mar-23
13:27
)
|
|
|
Caplin Point Laboratories fixes record date for interim dividend
(
Market Beat
-
Reports
06-May-21
16:17
)
|
|
|
Volumes spurt at Caplin Point Laboratories Ltd counter
(
Hot Pursuit
-
19-Aug-24
14:30
)
|
|
|
|
|
|
Other Stories |
|
|
|
|
|
|
|
|
|
|
|
|
|